Floatz logo

Auto-Cd34+ Cells

Advanced Coronary Heart Disease

Lisata Therapeutics, Inc.Cell therapyPhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Advanced Coronary Heart Disease cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
Ezetimibe
Canadian Collaborative Research Network
Phase 4BBB
Rivaroxaban
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BBB
SIMVASTATIN
University of Washington
Phase 4BBB
Ranolazine
OBS Pakistan
Phase 4BBB

View all 50 →

Same molecule, other indications

Auto-Cd34+ Cells is also rated in:

myocardial ischemiaDormant
BB
Indicative ·
66 / 100
View asset →
Leg PainDormant
CCC
Indicative ·
52 / 100
View asset →
ulcer diseaseDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →